- Education: MPH, Applied Clinical and Preclinical Research minor, The Ohio State University; PharmD, University of Nebraska Medical Center; BS, Capital Medical University.
- Certifications: Teaching & Learning Training Certificate; Health Outcomes Research Methods Certificate; NIH Clinical Research Certificate; Clinical Trials Operations; Systematic Review & Meta-Analysis; Biostatistics in Public Health
- Licensure: Pharmacist, Ohio Board of Pharmacy
- Special Educational Experiences: Postdoctoral fellowship program at The Ohio State University(OSU)
Health outcomes, pharmacotherapy, obesity/weight loss treatments, substance use disorders, psychiatric comorbidities, H. pylori treatment, medication adherence, cost-effectiveness research.
Research Methods and Biostatistics; Principles of Therapeutics; Integrated Pharmacotherapy; Literature Evaluation
PHRM 5113 Research Methods and Biostatistics
Health outcomes research, systematic reviews/meta-analyses, cost-effectiveness, obesity pharmacotherapy, opioid use disorder, psychiatric comorbidities, H. pylori infection
ACCP Annual Meeting Resident/Fellow Travel Award 2023; ACCP DEIA Annual Meeting Travel Award 2024
- American College of Clinical Pharmacy (ACCP)
- American Society of Health-System Pharmacists (ASHP)
- American Association of Psychiatric Pharmacists (AAPP)
- International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
- American Diabetes Association (ADA)
ACCP Health Outcomes PRN Secretary/Treasurer
- Liu L, Xiong G, Zhao H, Shi H, Liang M, Nahata MC. Trends in Weight Loss Attempts and Strategies Among US Adolescents With Overweight or Obesity. Obesity (Silver Spring). 2026;34(5):1101-1114.
- Liu L, Tao H, Zhao H, et al. Patterns of Dietary Supplement Use for Weight Loss Among U.S. Adults With Obesity: NHANES 2007-2020. J Obes. 2026;2026(1):e6761414.
- Liu L, Cui J, Neidecker MV, Nahata MC. Tirzepatide vs semaglutide and liraglutide for weight loss in patients with overweight or obesity without diabetes: A short-term cost-effectiveness analysis in the United States. J Manag Care Spec Pharm. 2025;31(5):441-450.
- Zhao X,Liu L, Zhang L, Zhao P, Jiang W, Nahata MC. The global burden of mental and substance use disorders among adolescents and young adults. Mol Psychiatry. Published online February 28, 2026. Doi:10.1038/s41380-026-03503-9
- Liu L, Zhang C, Nahata MC. Trends in Treatment Need and Receipt for Substance Use Disorders in the US. JAMA Netw Open. 2025;8(1):e2453317
- Liu L, Wang K, Neidecker MV, Yang H, Nahata MC. Cost-Effectiveness of First-Line Regimens for Helicobacter pylori Infection in the United States. Am J Gastroenterol. Published online January 21, 2026. Doi:10.14309/ajg.0000000000003924
- Liu L, Wang A, Shi H, Tao H, Nahata MC. Efficacy and safety of probiotics and synbiotics for functional constipation in children: A systematic review and meta-analysis of randomized clinical trials. Clin Nutr. 2023;42(10):1817-1826.
- Liu L, Shi H, Shi Y, et al. Vonoprazan-based therapies versus PPI-based therapies in patients with H. pylori infection: Systematic review and meta-analyses of randomized controlled trials. Helicobacter. 2024;29(3):e13094.
- Ligang Liu - Google Scholar